European Journal of Chemistry

Identification of degradation products in Aripiprazole tablets by LC-QToF mass spectrometry



Main Article Content

Gosula Venkat Rami Reddy
Avvaru Praveen Kumar
Bobba Venkateswara Reddy
Poonam Kumar
Ham Dutt Gauttam

Abstract

This paper describes the separation, identification and proposed structures of the degradation products formed during degradation analysis of aripiprazole in its final dosage form by high performance liquid chromatography (HPLC) coupled with quadrupole time-of-flight mass spectrometry (QToF-MS). The drug product was subjected to stress conditions including acid, base, thermal, oxidation, humidity and photolytic degradations. Aripiprazole was found to be stable in all conditions except in thermal and peroxide degradations. The degradation impurities were first separated by HPLC and then identified using QToF mass spectrometry. QToF mass spectrometer provided high order of mass accuracy for unknown impurities and their fragment ions to explore the elemental composition. Based on the fragmentation pattern, the possible structures of the unknown impurities were proposed. To the best of our knowledge, there were no methods available to identify the impurities during degradation of aripiprazole tablets by liquid chromatography-mass spectrometry.

1_1_20_27_800


icon graph This Abstract was viewed 6753 times | icon graph Article PDF downloaded 2749 times

How to Cite
(1)
Reddy, G. V. R.; Kumar, A. P.; Reddy, B. V.; Kumar, P.; Gauttam, H. D. Identification of Degradation Products in Aripiprazole Tablets by LC-QToF Mass Spectrometry. Eur. J. Chem. 2010, 1, 20-27.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Tamminga, C. A. J. Neural Transm. 2002, 109, 411-420.
doi:10.1007/s007020200033
PMid:11956961

[2]. Burris, K. D.; Molski, T. F.; Xu, C.; Ryan, E.; Tottori, K.; Kikuchi, T.; Yocca, F. D.; Molinoff, P. B. J. Pharmacol. Exp. Ther. 2002, 302, 381-389.
doi:10.1124/jpet.102.033175
PMid:12065741

[3]. Jordan, S.; Koprivica, V.; Chen, R.; Tottori, K.; Kikuchi, T.; Altar, C.A. Eur. J. Pharmacol. 2002, 441, 137-140.
doi:10.1016/S0014-2999(02)01532-7

[4]. Hirose, T.; Uwahodo, Y.; Yamada, S.; Miwa, T.; Kikuchi, T.; Kitagawa, H.; Burris, K. D.; Altar, C. A.; Nabeshima, T. J. Psychopharmacol. 2004, 18, 375-383.
doi:10.1177/026988110401800308
PMid:15358981

[5]. Kane, J. M.; Carson, W. H.; Saha, A. R.; McQuade, R. D.; Ingenito, G. G.; Zimbroff, D. L.; Ali, M. W. J. Clin. Psychiatry 2002, 63, 763-771.

[6]. Potkin, S. G.; Saha, A. R.; Kujawa, M. J.; Carson, W. H.; Ali, M.; Stock, E.; Stringfellow, J.; Ingenito, G.; Marder, S. R. Arch. Gen. Psychiatry 2003, 60, 681-690.
doi:10.1001/archpsyc.60.7.681
PMid:12860772

[7]. Kasper, S.; Lerman, M. N.; McQuade, R. D.; Saha, A.; Carson, W. H.; Ali, M.; Archibald, D.; Ingenito, G.; Marcus, R.; Pigott, T. Int. J. Neuropsychopharmacol. 2003, 6, 325-337.
doi:10.1017/S1461145703003651
PMid:14609439

[8]. Ribeiro, Y. A.; de Oliveira, J. D. S.; Leles, M. I. G.; Juiz, S. A.; Ionashiro, M. J. Therm. Anal. 1996, 46, 1645-1655.
doi:10.1007/BF01980770

[9]. Zhou, W.; Gilpin, R. K. J. Pharm. Sci. 2004, 93, 1545-1556.
doi:10.1002/jps.20082
PMid:15124212

[10]. Berridge, J. C. J. Pharm. Biomed. Anal. 1995, 14, 7-12.
doi:10.1016/0731-7085(95)01573-6

[11]. Branch, S.K. J. Pharm. Biomed. Anal. 2005, 38, 798-805.
doi:10.1016/j.jpba.2005.02.037
PMid:16076542

[12]. Roy, J. AAPS PharmSciTech 2002, 3, 1-8.
doi:10.1208/pt030206
PMid:12916943

[13]. Zuo, X. C.; Wang, F.; Xu, P.; Zhu, R. H.; Li, H. D. Chromatographia, 2006, 64, 387-391.
doi:10.1365/s10337-006-0037-1

[14]. Masanori, K.; Yasuo, M.; Yukihiro, H.; Takahiko, O. J. Chromatogr. B 2005, 822, 294-299.
doi:10.1016/j.jchromb.2005.06.023
PMid:16005688

[15]. Hui-Ching, H.; Chin-Hung, L.; Tsuo-Hung, L.; Tsung-Ming, H.; Hsien-Jane, C.; Yu-Chun, W.; Ying Lung, T. J. Chromatogr. B, 2007, 856, 57-61.
doi:10.1016/j.jchromb.2007.05.026
PMid:17602901

[16]. Shah, V. P.; Kamal, K. M.; Shrikant, D.; Iain, J. M.; Jerome, P. S.; Avraham, Y.; Thomas, L.; Viswanathan, C. T.; Edgar, C.; McDowall, R. D.; Kenneth, A. P.; Sidney, S. J. Pharm. Sci. 1992, 81, 309-312.
doi:10.1002/jps.2600810324

[17]. Zha, J. P., Xu, H. J., Wang, Y. Z., Yang, S. G., Jia, C. X., Hou, Z. F. Chin. Pharm. J. 2005, 40, 137-139.

[18]. Srinivas, K. S. V.; Buchireddy, R.; Madhusudhan, G.; Mukkanti, K.; Srinivasulu, P. Chromatographia 2008, 68, 635-640.
doi:10.1365/s10337-008-0739-7

[19]. ICH Topic Q1A (R2) 2003 Stability Testing of new Drug Substances and Products, CPMP/ICH/2736/99.

[20]. Lacorte, S.; Fernandez-Alba, A. R. Mass Spectrom. Rev. 2006, 25, 866-880.
doi:10.1002/mas.20094
PMid:16752429

[21]. Schmid, R. P.; Weickhardt, C. Int. J. Mass Spectrom. 2001, 206, 181-190.
doi:10.1016/S1387-3806(00)00311-0

[22]. Ferrer, I.; Garcı’a-Reyes, J. F.; Fernandez-Alba, A. Trends in Anal. Chem. 2005, 24, 2005.

[23]. Petrovic, M.; Gros, M.; Barcelo, D. J. Chromatogr. A 2006, 1124, 68-81.
doi:10.1016/j.chroma.2006.05.024
PMid:16759662

[24]. (WO/2003/064393) Thio-carbostyril derivative, its N-oxides and the N-oxides of aripiprazole.

Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).